Mengjie Niu

Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs

Ying Li, Yang Li, Liang Dong et al. · Acta Pharmacologica Sinica · 2019 · 71 citations · Full text

Inflammation, Hypertension, Pulmonary Arterial Hypertension +14

TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun

Ying Li, Zhiwei Yang, Weijie Li et al. · Oncotarget · 2016 · 44 citations · Full text

Medicine, Receptor Tyrosine Kinase, Immunology +14

Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients with diagnosis of pulmonary embolism for the first time in real world

Yongping Yu, Yang Li, Yuhai Zhang et al. · The Clinical Respiratory Journal · 2018 · 29 citations · Full text

Interventional therapy in sarcoidosis‐associated pulmonary arterial stenosis and pulmonary hypertension

Lingli Liu, Jian Xu, Yuhai Zhang et al. · The Clinical Respiratory Journal · 2015 · 24 citations

Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats

Jingwen Xia, Yang Li, Liang Dong et al. · Frontiers in Pharmacology · 2018 · 21 citations · Full text

Hypertension, Cellular Pharmacology, Pharmacotherapy +27